Last updated: April 22, 2026

Application No. 19/334,256

Untitled Application

Unknown

Filed

1600

Priority

Sep 20, 2024 — provisional 63/696,952

Examiner

FAUST, AMBER KATHLEEN

Art Unit

1643

Tech Center

BOSTON MEDICAL CENTER CORPORATION

Assignee

BOSTON MEDICAL CENTER CORPORATION

OA Round

2 (Non-Final)

This examiner grants 64% of cases after interview

— +47.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 56 resolved cases, 2023–2026

Examiner Intelligence

FAUST, AMBER KATHLEEN View full profile →

Grants 64% of resolved cases

Career Allowance Rate

36 granted / 56 resolved

+4.3% vs TC avg

Strong +48% interview lift

Without

With

+47.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

46 currently pending

Career history

102

Total Applications

across all art units

Statute-Specific Performance

§101

3.2%

-36.8% vs TC avg

§103

32.0%

-8.0% vs TC avg

§102

18.7%

-21.3% vs TC avg

§112

25.0%

-15.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 56 resolved cases

Prosecution Timeline

1600

Application Filed

Dec 11, 2025

Non-Final Rejection

Mar 11, 2026

Response Filed

Apr 08, 2026

Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/622,307

Patent 12600783

ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

4y 3m to grant Granted Apr 14, 2026

17/860,416

Patent 12534524

Manufacturing Methods for Producing Anti-TNF Antibody Compositions

3y 6m to grant Granted Jan 27, 2026

17/438,804

Patent 12527784

COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING SMALL CELL LUNG CANCER

4y 4m to grant Granted Jan 20, 2026

18/915,927

Patent 12479923

CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

1y 1m to grant Granted Nov 25, 2025

19/172,374

Patent 12435140

ANTIGEN BINDING POLYPEPTIDES

6m to grant Granted Oct 07, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

64%

Grant Probability

99%

With Interview (+47.9%)

3y 7m

Median Time to Grant

Moderate

PTA Risk

Based on 56 resolved cases by this examiner. Grant probability derived from career allowance rate.